netFormulary
 Report : A-Z HCD items in Formulary 17/06/2021 22:08:42
[Back]
 
Section Status CCG Name
10.01.03 Formulary CCG Abatacept 
01.05.03 Formulary CCG Adalimumab 
10.01.03 Formulary CCG Adalimumab 
13.05.03 Formulary CCG Adalimumab 
11.08.02 Formulary CCG Aflibercept 
13.05.01 Formulary CCG Alitretinoin 
10.01.03 Formulary CCG Apremilast rheumatology
13.05.03 Formulary CCG Apremilast Dermatology
10.01.03 Formulary CCG Baricitinib 
13.05.03 Formulary CCG Baricitinib Olumiant
13.05.03 Formulary CCG Brodalumab Dermatology
11.08.02 Formulary CCG Brolucizumab Beovu
06.07.02 Restricted Use CCG Buserelin 
10.01.03 Formulary CCG Certolizumab Pegol 
13.05.03 Formulary CCG Certolizumab pegol 
09.01.03 Formulary CCG Deferasirox Exjade
06.06.02 Formulary CCG Denosumab Prolia
09.01.03 Formulary CCG Desferrioxamine Mesilate Desferal
11.04.01 Formulary CCG Dexamethasone intravitreal implant 
13.05.02 Formulary CCG Dimethyl Fumarate  
08.01.05 Formulary CCG Dupilumab 
09.01.04 Formulary CCG Eltrombopag 
01.04.02 Formulary CCG Eluxadoline 
04.07.04.02 Formulary CCG Erenumab Aimovig
10.01.03 Formulary CCG Etanercept Rheumatology
13.05.03 Formulary CCG Etanercept 
10.01.03 Formulary CCG Filgotinib  Jyseleca
11.04.01 Formulary CCG Fluocinolone intravitreal implant 
04.07.04.02 Formulary CCG Fremanezumab Ajovy
04.07.04.02 Formulary CCG Galcanezumab Emgality
01.05.03 Formulary CCG Golimumab Gastroenterology
10.01.03 Formulary CCG Golimumab 
03.04.02 Formulary CCG Grass pollen extract Grazax
13.05.03 Formulary CCG Guselkumab dermatology
06.05.01 Restricted Use CCG Human Menopausal Gonadotrophins Menopur
01.05.03 Formulary CCG Infliximab 
10.01.03 Formulary CCG Infliximab 
13.05.03 Formulary CCG Infliximab 
13.05.03 Formulary CCG Ixekizumab dermatology
09.01.04 Formulary CCG Lusutrombopag 
02.03.02 Restricted Use CCG Mexiletine Mexitil unlicensed special
11.08.02 Formulary CCG Ocriplasmin Jetrea
09.02.01.01 Formulary CCG Patiromer Sorbitex Calcium Veltassa
07.04.02 Formulary CCG Pentosan polysulfate Elmiron
06.04.01.02 Restricted Use CCG Progesterone Cyclogest
11.08.02 Formulary CCG Ranibizumab 
05.01.07 Formulary CCG Rifaximin 
04.09.03 Formulary CCG Riluzole Rilutek
13.05.03 Formulary CCG Risankizumab Dermatology
10.01.03 Formulary CCG Rituximab (rheumatology) 
03.03.03 Formulary CCG Roflumilast Daxas
09.01.04 Formulary CCG Romiplostim 
10.01.03 Formulary CCG Sarilumab 
10.01.03 Formulary CCG Secukinumab Rheumatology
13.05.03 Formulary CCG Secukinumab 
09.02.01.01 Formulary CCG Sodium Zirconium Cyclosilicate Lokelma
06.05.01 Formulary CCG Somatropin 
13.05.03 Formulary CCG Tildrakizumab Dermatology
10.01.03 Formulary CCG Tocilizumab 
01.05.03 Formulary CCG Tofacitinib Gastroenterology
10.01.03 Formulary CCG Tofacitinib citrate 
06.05.02 Formulary CCG Tolvaptan Jinarc
10.01.03 Formulary CCG Upadacitinib 
01.05.03 Formulary CCG Ustekinumab Gastroenterology
10.01.03 Formulary CCG Ustekinumab rheumatology
13.05.03 Formulary CCG Ustekinumab 
01.05.03 Formulary CCG Vedolizumab 
Shropshire and Telford Local Health Economy